Composición del ETF BIB (NASDAQ) — página 7 | MetaTrader

Ver el calendario completo

Visión general Todos los activos Mapa de calor

Activos clave Valor de mercado Cantidad de acciones Participación, %

NTLA Intellia Therapeutics, Inc. 61.47 K 4 369.00 0.0835%

A

ATAI AtaiBeckley, Inc. 60.83 K 13.43 K 0.0826%

TSHA Taysha Gene Therapies, Inc. 59.45 K 10.13 K 0.0807%

INVA Innoviva, Inc. 58.69 K 2 740.00 0.0797%

AMLX Amylyx Pharmaceuticals, Inc. 58.25 K 4 059.00 0.0791%

ANAB AnaptysBio, Inc. 56.95 K 1 023.00 0.0773%

PGEN Precigen, Inc. 56.77 K 13.08 K 0.0771%

INBX Inhibrx Biosciences, Inc. 55.85 K 537.00 0.0758%

GLUE Monte Rosa Therapeutics, Inc. 55.54 K 2 818.00 0.0754%

VIR Vir Biotechnology, Inc. 55.43 K 5 810.00 0.0753%

GHRS GH Research plc 55.03 K 2 294.00 0.0747%

ARDX Ardelyx, Inc. 54.76 K 9 066.00 0.0743%

FTRE Fortrea Holdings, Inc. 53.17 K 3 455.00 0.0722%

MBX MBX Biosciences, Inc. 52.18 K 1 658.00 0.0708%

BCAX Bicara Therapeutics, Inc. 50.96 K 2 343.00 0.0692%

KalVista Pharmaceuticals, Inc. 50.25 K 1 870.00 0.0682%

SEPN Septerna, Inc. 50.04 K 1 657.00 0.0679%

URGN UroGen Pharma Ltd. 48.66 K 1 730.00 0.0661%

HROW Harrow, Inc. 48.24 K 1 370.00 0.0655%

MAZE Maze Therapeutics, Inc. 47.05 K 1 778.00 0.0639%

1
...
5
6
7
8
9
10
...
13

Noticias

Heidi Overton emerge como principal candidata a comisionada de la FDA